Evidence map›Paper›PMID 42551425›Full record

ArticleCell2026

Distinct cellular phenotypes of language and executive decline in amyotrophic lateral sclerosis.

Joana Petrescu, Cláudio Gouveia Roque, Christopher A Jackson, Aidan C Daly, Zoé Butti, Kristy Kang, Obadele Casel, Matthew Leung, Luke Reilly, Jacqueline Eschbach and 6 more

Abstract read
In one paragraph

Article in Cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Joana PetrescuCenter for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013, USA; Center for Motor Neuron Biology and Disease, Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
Cláudio Gouveia RoqueCenter for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013, USA.
Christopher A JacksonCenter for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013, USA.
Aidan C DalyCenter for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013, USA.
Zoé ButtiCenter for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013, USA.
Kristy KangCenter for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013, USA.
Obadele CaselCenter for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013, USA.
Matthew LeungCenter for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013, USA.
Luke ReillyCenter for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013, USA.
Jacqueline EschbachCenter for Motor Neuron Biology and Disease, Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
Brhan GebremedhinCenter for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013, USA.
Karina McDadeCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4TG, UK; UK Dementia Research Institute, University of Edinburgh, Edinburgh EH16 4SB, UK.
Jenna M GregoryInstitute of Medical Sciences, University of Aberdeen, Aberdeen, UK; Department of Pathology, NHS Grampian Tissue Biorepository, Aberdeen, UK.
Richard BonneauMachine Learning for Drug Discovery, Genentech, Roche, 1 DNA Way, South San Francisco, CA, USA.
Colin SmithCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4TG, UK; UK Dementia Research Institute, University of Edinburgh, Edinburgh EH16 4SB, UK.
Hemali PhatnaniCenter for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013, USA; Center for Motor Neuron Biology and Disease, Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: hphatnani@nygenome.org.

Funding

The Physical Biology of Neurodegeneration in Sporadic Amyotrophic Lateral Sclerosis/Frontotemporal DementiaR01NS127186 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HOLT, LIAM J, PHATNANI, HEMALI · 2021 to 2025
$8.2M
Integrating Spatial Multi-omics and Clinical Covariates to Identify Mechanisms of Disease in ALS-FTDR01NS118183 · NINDS · NEW YORK GENOME CENTER · PI Hemali Phatnani · 2020 to 2026
$4.7M
Connecting TDP-43 Pathology to the Molecular Profiles of NeurodegenerationRF1NS118570 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GALE HAMMELL, MOLLY, PHATNANI, HEMALI · 2020 to 2020
$3.7M
Spatially Resolved Dynamics of Molecular Pathology and Intercellular Interactions in Amytrophic Lateral SclerosisR01NS116350 · NINDS · NEW YORK GENOME CENTER · PI Hemali Phatnani · 2020 to 2026
$3.6M
Connecting TDP-43 Pathology to the Molecular Profiles of NeurodegenerationR01NS118570 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GALE HAMMELL, MOLLY, PHATNANI, HEMALI · 2024 to 2024
$880k
Clinicopathologic correlates of cognitive impairment in amyotrophic lateral sclerosis and frontotemporal dementia spectrum disorders (ALS-FTD)F30AG072766 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PETRESCU, JOANA · 2022 to 2024
$135k
NIA NIH HHS F30 AG072766NINDS NIH HHS R01 NS116350NINDS NIH HHS R01 NS118183NINDS NIH HHS R01 NS118570NINDS NIH HHS R01 NS127186NINDS NIH HHS RF1 NS118570
6 · The paper itself

Abstract

Cognitive manifestations, including impairments in language and executive functions, are seen in amyotrophic lateral sclerosis (ALS), but the underlying mechanisms remain unclear. We mapped prefrontal cortex regions from ALS patients by integrating spatial and single-nucleus transcriptomics in a cognitively stratified patient cohort. We uncover that cognitive impairment in ALS is associated with distinct patterns of neuronal dysfunction and glial-vascular dysregulation that vary by region and cognitive subtype. Executive dysfunction is linked to reduced mitochondrial and synaptic activity in deep-layer dorsolateral prefrontal cortex neurons, whereas language-related deficits track with a diffuse pan-regional response involving glial and vascular abnormalities. Our analyses, validated by multiplexed imaging, further identify signatures in the prefrontal cortex that span both motor and cognitive phenotypes, including a multicellular gliosis response. The findings reveal that clinical heterogeneity in ALS is driven by phenotype-specific cellular interactions in motor and non-motor regions of the brain.

Indexed as

Amyotrophic Lateral SclerosisCognitive DysfunctionExecutive FunctionLanguageAgedFemaleHumansMaleMiddle AgedMitochondriaNeuronsPhenotypePrefrontal CortexALSALS-FTDALS-FTSDcognitive heterogeneitycognitive impairment in ALSexecutive functionlanguagemultimodal analysisspatial biologyverbal fluency

Identifiers

PMID42551425
PMCPMC13480947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.